Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Other financing activities (2016 - 2025)

Historic Other financing activities for Neuroone Medical Technologies (NMTC) over the last 6 years, with Q4 2025 value amounting to $22920.0.

  • Neuroone Medical Technologies' Other financing activities rose 758.04% to $22920.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$96181.0, marking a year-over-year decrease of 276650.96%. This contributed to the annual value of $20000.0 for FY2024, which is 9147.94% down from last year.
  • Latest data reveals that Neuroone Medical Technologies reported Other financing activities of $22920.0 as of Q4 2025, which was up 758.04% from $21305.0 recorded in Q4 2024.
  • In the past 5 years, Neuroone Medical Technologies' Other financing activities ranged from a high of $183359.0 in Q1 2023 and a low of -$216599.0 during Q3 2024
  • Over the past 4 years, Neuroone Medical Technologies' median Other financing activities value was $37698.0 (recorded in 2023), while the average stood at $34962.6.
  • In the last 5 years, Neuroone Medical Technologies' Other financing activities surged by 13991.6% in 2023 and then tumbled by 4348.51% in 2024.
  • Quarter analysis of 4 years shows Neuroone Medical Technologies' Other financing activities stood at $15713.0 in 2022, then skyrocketed by 139.92% to $37698.0 in 2023, then plummeted by 43.49% to $21305.0 in 2024, then grew by 7.58% to $22920.0 in 2025.
  • Its last three reported values are $22920.0 in Q4 2025, $21305.0 for Q4 2024, and -$216599.0 during Q3 2024.